Table 2a. Components of the primary mITT analysis.

			16 weeks	24 weeks	Total
		Randomised	602	602	1204
		Included in analysis (assessable)	572	573	1145
Favourable	Completed treatment and clinically well (without retreatment or otherwise unfavourable) at 72 weeks		556	555	1111
	Total favourable (% of assessable)		556 (97)	555 (97)	1111 (97)
Unfavourable	Death from any cause after week 16		7	12	19
	LTFU after week 16 but during treatment period		0	1	1
	TB events	TB recurrence	6	4	10
		Treatment extension (treatment failure)	2	0	2
		Restart* (treatment failure)	1	1	2
	Total unfavourable (% of assessable)		16 (3)	18 (3)	34 (3)

Data presented as number of participants (%). mITT = modified intention to treat.

^*Both participants had treatment restarted after defaulting on treatment.